Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brandow

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Blood Advances|July 1, 2021
Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell diseaseLana Mucalo, Amanda M Brandow, Mahua Dasgupta, et al.
Blood Advances|June 20, 2020
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic painAmanda M Brandow, C Patrick Carroll, Susan Creary, et al.
JMIR Public Health and Surveillance|June 28, 2023
Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation StudyAshima Singh, Marci K Sontag, Mei Zhou, et al.
Blood Advances|December 4, 2019
2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovationsM Hassan Murad, Robert I Liem, Eddy S Lang, et al.
Journal of Proteome Research|May 15, 2025
Comparative Proteomic Analysis Reveals Altered Ciliary Proteins in Sickle Cell DiseaseAshraf M Mohieldin, Madison Spencer, Carter Bernal, et al.
Journal of Clinical Pharmacology|July 24, 2015
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemiaJeremie H Estepp, Chiara Melloni, Courtney D Thornburg, et al.
Blood Advances|July 11, 2024
COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network StudyAlan R Anderson, John J Strouse, Deepa Manwani, et al.
Pediatric Blood & Cancer|July 17, 2023
Return visit rates after an emergency department discharge for children with sickle cell pain episodesKeli D Coleman, Kenneth McKinley, Angela M Ellison, et al.
Pediatric Blood & Cancer|May 3, 2025
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell DiseaseKeli D Coleman, Kenneth McKinley, Angela M Ellison, et al.
JAMA Pediatrics|September 2, 2025
Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell PainIbrahim Gwarzo, Keli D Coleman, Kenneth McKinley, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Blood Advances|July 1, 2021
Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell diseaseLana Mucalo, Amanda M Brandow, Mahua Dasgupta, et al.
Blood Advances|June 20, 2020
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic painAmanda M Brandow, C Patrick Carroll, Susan Creary, et al.
JMIR Public Health and Surveillance|June 28, 2023
Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation StudyAshima Singh, Marci K Sontag, Mei Zhou, et al.
Blood Advances|December 4, 2019
2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovationsM Hassan Murad, Robert I Liem, Eddy S Lang, et al.
Journal of Proteome Research|May 15, 2025
Comparative Proteomic Analysis Reveals Altered Ciliary Proteins in Sickle Cell DiseaseAshraf M Mohieldin, Madison Spencer, Carter Bernal, et al.
Journal of Clinical Pharmacology|July 24, 2015
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemiaJeremie H Estepp, Chiara Melloni, Courtney D Thornburg, et al.
Blood Advances|July 11, 2024
COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network StudyAlan R Anderson, John J Strouse, Deepa Manwani, et al.
Pediatric Blood & Cancer|July 17, 2023
Return visit rates after an emergency department discharge for children with sickle cell pain episodesKeli D Coleman, Kenneth McKinley, Angela M Ellison, et al.
Pediatric Blood & Cancer|May 3, 2025
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell DiseaseKeli D Coleman, Kenneth McKinley, Angela M Ellison, et al.
JAMA Pediatrics|September 2, 2025
Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell PainIbrahim Gwarzo, Keli D Coleman, Kenneth McKinley, et al.
Pageof 8